Overall survival of oropharyngeal cancer patients treated with different treatment modalities

Journal of Craniofacial Surgery

Volumn 18, Issue 1, 2007, Pages 133-136

  Velich, Norbert ^a,b   Vaszilkó, Mihály ^a,b   Németh, Zsolt ^a,b   Szigeti, Krisztián ^a   Bogdán, Sándor ^a,b   Barabás, József ^a,b   Szabó, György ^a,b  

^a Semmelweis University ^*  (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Intra arterial chemotherapy; Oropharyngeal carcinoma; Overall survival

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OROPHARYNX CANCER; PALLIATIVE THERAPY; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; SURVIVAL RATE; TUMOR VOLUME;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; OROPHARYNGEAL NEOPLASMS; REGRESSION ANALYSIS;

EID: 33846488397     PISSN: 10492275     EISSN: None     Source Type: Journal    
DOI: 10.1097/SCS.0b013e31802ccde3     Document Type: Article

References (13)

1. Kovacs AF, Schiemann M, Turowski B. Combined modality treatment of oral and oropharyngeal cancer including neoadjuvant intraarterial cisplatin and radical surgery followed by concurrent radiation and chemotherapywith weekly docetaxel - three years results of a pilot study. J Craniomaxillofac Surg 2002;30:112-120
2. Kovacs AF, Mose S, Bottcher HD, et al. Multimodality treatment including postoperative radiation and concurrent chemotherapy with weekly docetaxel is feasible and effective in patients with oral and oropharyngeal cancer. Strahlenter Onkol 2005;181:26-34
3. Fu KK. Combined-modality therapy for head and neck cancer. Oncology 1997;11:1781-1790
4. Al-Sarraf M, Pajak TF, Byhardt RW, et al. Postoperative radiotherapy with concurrent cisplatin appears to improve locoregional control of advanced, resectable head and neck cancers: RTOG 88-24. Int J Radiat Oncol Biol Phys 1997;37:777-782
5. Kovacs AF, Ghahremani MT, Stefenelli U, et al. Postoperative chemotherapy with cisplatin and 5-fluorouracil in cancer of the oral cavity and the oropharynx - long-term results. J Chemother 2003;15:495-502
6. Giralt JL, Gonzalez J, del Campo JM, et al. Preoperative induction chemotherapy followed by concurrent chemoradiotherapy in advanced carcinoma of the oral cavity and oropharynx. Cancer 2000;89:939-945
7. Mantz CA, Vokes EE, Stenson K, et al. Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced oropharyngeal cancer. Cancer J 2001;7:140-148
8. Johansen LV, Grau C, Overgaard J. Squamous cell carcinoma of the oropharynx-an analysis of treatment results in 289 consecutive patients. Acta Oncol 2000;39:985-994
9. Mohr C, Bohndorf W, Carstens J, et al. Preoperative radiochemotherapy and radical surgery in comparison with radical surgery alone. A prospective, multicentric, randomized DOSAK study of advanced squamous cell carcinoma of the oral cavity and the oropharynx (a 3-year follow-up). Int J Oral Maxillofac Surg 1994;23:140-148
10. Kovacs AF. Intra-arterial induction high-dose chemotherapy with cisplatin for oral and oropharyngeal cancer: long-term results. Br J Cancer 2004;90:1323-1328
11. Milazzo J, Mohit-Tabatabai MA, Hill GJ, et al. Preoperative intra-arterial infusion chemotherapy for advanced squamous cell carcinoma of the mouth and oropharynx. Cancer 1985;56:1014-1017
12. Szabo G, Kreidler J, Hollmann K, et al. Intra-arterial preoperative cytostatic treatment versus preoperative irradiation: a prospective, randomized study of lingual and sublingual carcinomas. Cancer 1999;86:1381-1386
13. Miller AB, Hoogstraten B, Staquet M, et al. Reporting results of cancer treatment. Cancer 1981;47:207-214